High blood calcium levels, or hypercalcemia, may in rare cases be a symptom of sarcoidosis, according to a case…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
Being Black or having restrictive lung disease, where it’s hard to take in enough air in a breath, were factors…
A woman who underwent a heart transplant for cardiac sarcoidosis later showed signs of sarcoidosis in the brain, a…
Nearly a quarter of sarcoidosis patients were found to have clinically silent cardiac involvement, in which standard heart…
The percentage of natural killer (NK) immune cells in the airways were predictive of a more advanced stage of lung…
Acthar Gel (repository corticotropin injection) may be a cost-effective approach relative to standard-of-care glucocorticoid therapy for adults with advanced…
The European Medicines Agency (EMA) has granted XTMAB-16, Xentria‘s investigational antibody therapy, orphan drug designation for sarcoidosis. The…
EFZO-FIT, a Phase 3 trial that’s testing treatment candidate efzofitimod in people with pulmonary sarcoidosis, is continuing  following…
Workplace exposure to silica, mold/mildew, and pesticides were associated with an increased risk of pulmonary sarcoidosis in a recent…
Treatment with tumor necrosis factor-alpha (TNF-a) inhibitors — which block a type of immune protein in the body —…